Walleye Capital LLC Amylyx Pharmaceuticals, Inc. Call Options Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$2.71 - $19.57 $34,146 - $246,582	-12,600 Reduced 63.32%	7,300 $20,000
Q4 2023 Feb 14, 2024	SELL	$12.07 - $18.46 $62,764 - $95,992	-5,200 Reduced 20.72%	19,900 $292,000
Q3 2023 Nov 14, 2023	BUY	$18.08 - $23.45 $207,919 - $269,675	11,500 Added 84.56%	25,100 $459,000
Q2 2023 Aug 14, 2023	BUY	$20.98 - $31.42 $285,328 - $427,312	13,600 New	13,600 $293,000
Q4 2022 Feb 14, 2023	BUY	$29.75 - $39.26 $86,275 - $113,854	2,900 New	2,900 $107,000

127

44.4M

235K

530K

Ticker AMLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,533,200
Market Cap $237M
Description
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.